Oncology & Cancer

Niraparib extends time without symptoms in ovarian cancer

(HealthDay)—Women with recurrent ovarian cancer who receive the poly ADP ribose polymerase (PARP) inhibitor niraparib as maintenance therapy after treatment have both more time without side effects and significantly longer ...

Oncology & Cancer

New myeloma treatment options show promise

(HealthDay)—New multiple myeloma treatment options appear promising for patients aged 65 years and younger and for newly diagnosed patients who are ineligible for stem-cell transplantation, according to two studies published ...

Oncology & Cancer

Treatment beneficial in smoldering multiple myeloma

(HealthDay)—For patients with smoldering multiple myeloma, treatment with lenalidomide plus dexamethasone correlates with delayed progression and improved survival, according to a study published in the Aug. 1 issue of ...

Oncology & Cancer

Immune-boosting colorectal cancer drug shows promise

New data on an emerging treatment that aims to fight colorectal cancer by stimulating the immune system have been presented at the ESMO 15th World Congress on Gastrointestinal Cancer.

Obstetrics & gynaecology

Researcher examines the risks of early methadone exposure

(Medical Xpress)—Longitudinal studies of children exposed to methadone in the womb need to accompany methadone maintenance treatment for drug-addicted pregnant mothers, according to a research team led by a University of ...

page 1 from 4